Henry Schein
HSIC stock analysis · Health Care · Health Care Distributors
As of · fund-implied per-share value
Fund holding value ÷ shares held. Not a live quote; not adjusted for later stock splits.
View SEC fund filing ↗Price × SEC outstanding shares. Shares measured 2026-06-27. Approximate; share and price dates can differ.
View share-count filing ↗DCF value
Equity cash-flow scenario · SEC outstanding shares at 2026-06-27 · -6.9% versus input cap
How this is calculated ↗Reverse DCF
Annual basis · read assumptions below
How this is calculated ↗Relative valuation
52 sector peers · median 26.0×
How this is calculated ↗Historical multiples
7 annual observations · snapshot P/E 23.5× · 13.7% versus history
How this is calculated ↗Free cash flow yield
Annual basis · read assumptions below
How this is calculated ↗ROIC / quality
Normalized tax · financing-capital proxy
How this is calculated ↗Value composite
Annual basis · read assumptions below
How this is calculated ↗12–1 price momentum
Split and corporate-action verification is incomplete for these fund observations. Verified adjusted endpoints are required for 12–1 momentum.
How this is calculated ↗Asset growth
Annual basis · read assumptions below
How this is calculated ↗Net payout yield
Requires reported dividends, repurchases and issuance; missing values are not zero.
How this is calculated ↗Accrual quality
Annual basis · read assumptions below
How this is calculated ↗Fundamental momentum
Annual basis · read assumptions below
How this is calculated ↗Follow the cash
ANNUAL · USDOperating cash flow and reinvestment over time
Annual USD. Negative bars use a compressed lower scale. Hover or inspect the financial history table for exact values.
Make the assumptions yours
How sensitive is the valuation?
| Return / Growth | 3.0% | 5.0% | 7.0% |
|---|---|---|---|
| 8.0% | $97.54 | $106.42 | $115.98 |
| 10.0% | $71.47 | $77.76 | $84.52 |
| 12.0% | $56.39 | $61.19 | $66.33 |
Annual financial history
Open SEC filings ↗| Fiscal year-end | Revenue | Net income | Operating cash flow | Capital expenditure | Assets |
|---|---|---|---|---|---|
| 2025-12-27 | 13.2B | 419M | 712M | 139M | 11.2B |
| 2024-12-28 | 12.7B | 398M | 848M | 148M | 10.2B |
| 2023-12-30 | 12.3B | 436M | 500M | 147M | 10.6B |
| 2022-12-31 | 12.6B | 566M | 602M | 96M | 8.6B |
| 2021-12-25 | 12.4B | 660M | 710M | 79M | 8.5B |
| 2020-12-26 | 10.1B | 420M | 599M | 49M | 7.8B |
| 2019-12-28 | 10B | 719.1M | 654.1M | 76.2M | 7.2B |
| 2018-12-29 | 9.4B | 562.1M | 684.7M | 71.3M | 8.5B |
USD, abbreviated. Restated annual history; not a point-in-time backtest. Missing values appear as dashes.
Trace the inputs
MODEL ANNUAL PERIOD| Input | Value | SEC tag / source | Filed |
|---|---|---|---|
| revenue | 13.2B | RevenueFromContractWithCustomerExcludingAssessedTax | 2026-02-24 |
| netIncome | 419M | ProfitLoss Explicit consolidated amount, including the portion attributable to noncontrolling interests. | 2026-02-24 |
| Parent/common earnings proxy | 398M | NetIncomeLoss | 2026-02-24 |
| cfo | 712M | NetCashProvidedByUsedInOperatingActivities | 2026-02-24 |
| capex | 139M | PaymentsToAcquireProductiveAssets | 2026-02-24 |
| operatingIncome | 653M | OperatingIncomeLoss | 2026-02-24 |
| assets | 11.2B | Assets | 2026-02-24 |
| equity | 3.9B | StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Explicit consolidated amount, including the portion attributable to noncontrolling interests. | 2026-02-24 |
| Parent book equity proxy | 3.2B | StockholdersEquity | 2026-02-24 |
| debt | 2.3B | LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities | 2026-02-24 |
| shortDebt | 764M | ShortTermBorrowings | 2026-02-24 |
| cash | 156M | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | 2026-02-24 |
| shares | 121.7M | WeightedAverageNumberOfDilutedSharesOutstanding | 2026-02-24 |
| dividends | — | Not reported under a supported tag | — |
| buybacks | 850M | PaymentsForRepurchaseOfCommonStock | 2026-02-24 |
| issuance | 250M | ProceedsFromIssuanceOfCommonStock | 2026-02-24 |